⌘K

Market Updates

Daily Market Updates, in bite-sized chunks.

Press Releases

Information unfiltered and straight from the source.

Latest Analysis

We cut through the bull and the bear to provide simple, engaging content for everyone.

Investing Ideas

Looking for a new idea, our investing ideas section is just what you’re looking for.

Market Reports & Guides

Our reports are packed full of unrivalled insight and analysis across a wide range of topics, industries and companies.

Energy

Materials

Industrials

Consumer Discretionary

Consumer Staples

Healthcare

Financials

Information Technology

Communication Services

Utilities

Real Estate

Articles

Our education section provides in-depth guides and articles across a range of topics.

Glossary

Our glossary is a great place to start if you’re new to the world of investing.

⌘K

Healthcare

Latest Analysis

Scales indicating Weight Loss

Promising Results for Amgen's MariTide

Amgen's MariTide shows promising weight-loss results but faces competition and side effect challenges.

Nov 27, 2024

Kelloggs Cereals

RFK Artificial Dye Risks: Impact on Food Giants

Kennedy's nomination and California's food dye ban could reshape the food industry, impacting major brands.

Nov 21, 2024

Merck Stock MRK on smartphone

Merck Eyes Incyte for Possible Acquisition

Merck (MRK) is rumored to be pursuing Incyte (INCY), prompting market volatility.

Nov 20, 2024

Press Releases

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx™ for Recurrent Pericarditis

Cardiol Therapeutics Inc

February 21, 2024

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Cardiol Therapeutics Inc

February 15, 2024

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

Cardiol Therapeutics Inc

January 9, 2024

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis

Cardiol Therapeutics Inc

November 1, 2023

Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Cardiol Therapeutics Inc

March 29, 2023

We use cookies

This website uses cookies in order to enhance the overall user experience.

Take a look at our Cookies Policy for more information.

Essential cookies

There are some cookies that we have to include in order for certain web pages to function. For this reason, they do not require your consent.

laravel_cookie_consent

1 year 1 month 1 day

Used to store the user's cookie consent preferences.
laravel_session

2 hours

Used to identify the user's browsing session.
XSRF-TOKEN

2 hours

Used to secure both the user and our website against cross-site request forgery attacks.

More details

Analytics cookies

We use these for internal research on how we can improve the service we provide for all our users. These cookies assess how you interact with our website.

_ga

2 years 2 months 2 days

Main cookie used by Google Analytics, enables a service to distinguish one visitor from another.
_ga_12345

2 years 2 months 2 days

Used by Google Analytics to persist session state.
_gid

1 day

Used by Google Analytics to identify the user.
_gat

1 minute

Used by Google Analytics to throttle the request rate.

More details